Tandem Diabetes Care, Inc. (TNDM): Price and Financial Metrics


Tandem Diabetes Care, Inc. (TNDM): $61.81

2.62 (+4.43%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

TNDM POWR Grades


  • Quality is the dimension where TNDM ranks best; there it ranks ahead of 71.47% of US stocks.
  • TNDM's strongest trending metric is Momentum; it's been moving down over the last 179 days.
  • TNDM's current lowest rank is in the Momentum metric (where it is better than 5.5% of US stocks).

TNDM Stock Summary

  • With a price/earnings ratio of 477.05, Tandem Diabetes Care Inc P/E ratio is greater than that of about 98.46% of stocks in our set with positive earnings.
  • Price to trailing twelve month operating cash flow for TNDM is currently 66.68, higher than 92.53% of US stocks with positive operating cash flow.
  • Over the past twelve months, TNDM has reported earnings growth of -193.46%, putting it ahead of merely 10.23% of US stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Tandem Diabetes Care Inc are CVLT, MIME, ZI, FTK, and PTC.
  • Visit TNDM's SEC page to see the company's official filings. To visit the company's web site, go to www.tandemdiabetes.com.

TNDM Valuation Summary

  • In comparison to the median Healthcare stock, TNDM's price/earnings ratio is 2854.52% higher, now standing at 1078.4.
  • Over the past 93 months, TNDM's price/sales ratio has gone down 8.7.
  • TNDM's price/sales ratio has moved down 8.7 over the prior 93 months.

Below are key valuation metrics over time for TNDM.

Stock Date P/S P/B P/E EV/EBIT
TNDM 2021-08-31 11.7 20.4 1078.4 379.2
TNDM 2021-08-30 11.7 20.5 1079.6 379.6
TNDM 2021-08-27 11.5 20.1 1060.5 373.1
TNDM 2021-08-26 11.6 20.3 1070.2 376.4
TNDM 2021-08-25 11.6 20.3 1071.9 377.0
TNDM 2021-08-24 11.7 20.5 1081.7 380.3

TNDM Growth Metrics

    The 2 year revenue growth rate now stands at 240.15%.
  • The 5 year price growth rate now stands at -26.67%.
  • Its 3 year net cashflow from operations growth rate is now at 99.71%.
TNDM's revenue has moved up $292,582,000 over the prior 18 months.

The table below shows TNDM's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 702.799 111.359 15.566
2021-09-30 660.868 106.961 21.758
2021-06-30 604.844 87.381 6.556
2021-03-31 541.941 73.985 -24.559
2020-12-31 498.83 24.669 -34.382
2020-09-30 439.163 28.874 -48.73

TNDM's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • TNDM has a Quality Grade of C, ranking ahead of 66.11% of graded US stocks.
  • TNDM's asset turnover comes in at 0.848 -- ranking 30th of 186 Medical Equipment stocks.
  • IVC, TCMD, and PSTV are the stocks whose asset turnover ratios are most correlated with TNDM.

The table below shows TNDM's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.848 0.534 0.036
2021-06-30 0.823 0.532 0.024
2021-03-31 0.785 0.523 -0.018
2020-12-31 0.849 0.522 -0.045
2020-09-30 0.897 0.524 -0.109
2020-06-30 1.040 0.526 -0.154

TNDM Price Target

For more insight on analysts targets of TNDM, see our TNDM price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $132.75 Average Broker Recommendation 1.62 (Moderate Buy)

TNDM Stock Price Chart Interactive Chart >

Price chart for TNDM

TNDM Price/Volume Stats

Current price $61.81 52-week high $155.86
Prev. close $59.19 52-week low $52.69
Day low $58.75 Volume 477,300
Day high $61.87 Avg. volume 741,823
50-day MA $72.19 Dividend yield N/A
200-day MA $111.86 Market Cap 3.95B

Tandem Diabetes Care, Inc. (TNDM) Company Bio


Tandem Diabetes Care, Inc. focuses on the design, development, and commercialization of various products for people with insulin-dependent diabetes in the United States. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. The company was founded in 2006 and is based in San Diego, California.


TNDM Latest News Stream


Event/Time News Detail
Loading, please wait...

TNDM Latest Social Stream


Loading social stream, please wait...

View Full TNDM Social Stream

Latest TNDM News From Around the Web

Below are the latest news stories about Tandem Diabetes Care Inc that investors may wish to consider to help them evaluate TNDM as an investment opportunity.

Tandem Diabetes Care, Inc. (TNDM) CEO John Sheridan on Q4 2021 Results - Earnings Call Transcript

Tandem Diabetes Care, Inc. (TNDM) Q4 2021 Earnings Conference Call February 22, 2022, 04:30 PM ET Company Participants Susan Morrison - EVP and CAO John Sheridan - President and CEO Leigh Vosseller - EVP and CFO Brian Hansen - EVP and Chief Commercial Officer Conference Call Participants Chris Pasquale -...

SA Transcripts on Seeking Alpha | February 23, 2022

Tandem Diabetes (TNDM) Q4 Earnings Lag Estimates, Revenues Top

Robust domestic and international pump shipments are driving Tandem Diabetes' (TNDM) fourth-quarter top line.

Yahoo | February 23, 2022

Tandem Diabetes Care GAAP EPS of $0.16 misses by $0.06, revenue of $210M beats by $11.17M

Tandem Diabetes Care press release (NASDAQ:TNDM): Q4 GAAP EPS of $0.16 misses by $0.06. Revenue of $210M (+24.9% Y/Y) beats by $11.17M....

Seeking Alpha | February 22, 2022

Tandem Diabetes Care, Inc. (TNDM) Q4 Earnings Lag Estimates

Tandem Diabetes Care, Inc. (TNDM) delivered earnings and revenue surprises of -20% and 6.08%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 22, 2022

Tandem Diabetes Care Announces Fourth Quarter and Full Year 2021 Financial Results and 2022 Financial Guidance

SAN DIEGO, February 22, 2022--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter and year ended December 31, 2021 and financial guidance for the year ending December 31, 2022.

Yahoo | February 22, 2022

Read More 'TNDM' Stories Here

TNDM Price Returns

1-mo -2.63%
3-mo -48.21%
6-mo -57.49%
1-year -37.32%
3-year -2.45%
5-year 663.09%
YTD -58.94%
2021 57.32%
2020 60.51%
2019 56.99%
2018 1,508.90%
2017 -89.02%

Continue Researching TNDM

Here are a few links from around the web to help you further your research on Tandem Diabetes Care Inc's stock as an investment opportunity:

Tandem Diabetes Care Inc (TNDM) Stock Price | Nasdaq
Tandem Diabetes Care Inc (TNDM) Stock Quote, History and News - Yahoo Finance
Tandem Diabetes Care Inc (TNDM) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5587 seconds.